BDX
BCAL FPO [BDX]
Healthcare · ASX Small Cap
$0.0650 +0.0%
Updated 9 Sep 2026 · Signals refresh every scan
Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when BDX triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- Watch out — volume is flowing out even as price holds up. Distribution pattern
- Drifting lower — down 5.8% over the last 5 days
- Beating the Small Ords index — relative strength of 1.19, so it's outpacing the pack
- Critical cash runway (1.0 quarters)
- Moderate P/S ratio (10.2x)
- Near 52-week low (13% of range)
- Small-cap ($20-100M)
- CANSLIM S: Tight float (49%)
- Sentiment is mixed — no strong consensus either way
- Altman Z-Score distress zone (1.42 < 1.81, low-confidence approx)
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Revenue declining (-15%)
- Piotroski F-Score weak (2/9, low-confidence approx)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 30% over the past year
- Revenue declining at -15% — the top line is shrinking
- The bigger volume days are the down days — volume-weighted momentum is negative (-1.36%/day)
Expected next for BDX
Window: 20 Oct to 3 Nov
The last 8 moved BDX +1.1% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →
Recent Catalysts
NONE BCAL Seeks Board Change at Genetic Signatures
NONE Meet The CEO FY 2026 Results Webinar 3 Sept 2026 at 1PM
NONE Appendix 4G and Corporate Governance Statement
LOW Investor Presentation September 2026
LOW Appendix 4E and Annual Report to shareholders
Recent ASX Announcements
| 2026-09-03 | BCAL Seeks Board Change at Genetic Signatures |
| 2026-09-03 | Investor Presentation September 2026 |
| 2026-08-31 | Meet The CEO FY 2026 Results Webinar 3 Sept 2026 at 1PM |
| 2026-08-28 | Appendix 4G and Corporate Governance Statement |
| 2026-08-28 | Appendix 4E and Annual Report to shareholders PRICE SENSITIVE |
Key Metrics
$24.0M
Market Cap
117K
Avg Volume
1.4x
Vol Ratio
$0.05 — $0.15
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-273.3%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | pass | Float: 49% |
| L | Leader vs Laggard | laggard | RS: -18 |
| I | Institutional Sponsorship | weak | Inst: 3% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
110 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track BDX and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required